SCHEMBL9399083

SCHEMBL9399083

COC(N)C1CCCN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6111365 1.00
SCHEMBL6204822 1.00
SCHEMBL6111674 1.00
SCHEMBL4974553 0.77 SLC6A3 (0.36)
SCHEMBL6226662 0.77 SLC6A3 (0.36)
SCHEMBL23603002 0.76
SCHEMBL4838694 0.76
Hydrochloric Acid SCHEMBL5559301 0.76 ALDH1A1 (0.37)
Hydrochloric Acid SCHEMBL5559307 0.76 ALDH1A1 (0.37)
SCHEMBL15166346 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2694532-B1 AUREOBASIDIN DERIVATIVES AND METHODS OF SYNTHESIS AUREOGEN BIOSCIENCES INC (US) 2021-04-21 EP disclosed
US-8980934-B2 Kinase inhibitors and method of treating cancer with same UNIVERSITY HEALTH NETWORK (CA) 2015-03-17 US disclosed
US-20140005167-A1 KINASE INHIBITORS AND METHOD OF TREATING CANCER WITH SAME UNIVERSITY HEALTH NETWORKS (CA) 2014-01-02 US disclosed
US-5342848-A Relaxation of vascular smooth muscle RHONE-POULENC RORER LIMITED (GB) 1994-08-30 US disclosed
WO-1991012242-A1 THIOFORMAMIDE DERIVATIVES RHONE-POULENC RORER S.A. (FR) 1991-08-22 WO disclosed